|
Click on the studies below to learn more:
Study Title:
Serum Proteomics: For Detection of Ovarian Cancer Using the Correlogic Systems, Inc. Serum Pattern Blood Test System
Study Title:
International Early Lung Cancer Action Project
Study Title:
I-ELCAP-Legacy Lung Screening and Smoking Cessation Project
Study Title:
Serum Proteomics: For Detection of Ovarian Cancer Using the Correlogic Systems, Inc. Serum Pattern Blood Test System
What is the purpose of this study?
In the United States, more than 20,000 women a year are diagnosed with ovarian cancer. Most of the women are diagnosed in the later stages of the disease.
The Correlogic Ovarian Test (OvaCheck) is a blood test being investigated for its use in the early detection of ovarian cancer.
Can I participate in this study?
- Are you 18 years or older?
- Are you scheduled for gynecologic surgery?
- Are you willing to provide a blood sample?
What do I need to do?
To participate in the ovarian cancer research study you will need to:
- Give researchers permission to collect information about your health history
- Complete a brief questionnaire
- Give two blood samples that amount to less than 4 tablespoons of blood
Why should I participate?
If you are interested in participating in this ovarian cancer research study, please contact:
Felicia Nash-DeBraux, research associate
Holy Cross Hospital, Clinical Research Department
301-754-7985
nashf@holycrosshealth.org
Principal Investigator: James Barter, MD, gynecology oncology surgeon
Return to top.
----------------------------------------------------------------------------------------------------------------------------------------------------------
Study Title:
International Early Lung Cancer Action Project
Study Title:
I-ELCAP-Legacy Lung Screening and Smoking Cessation Project
What is the purpose of this study?
The purpose of this study is to determine whether a CT scan can detect lung cancer or other diseases in the early stages. A CT scan can detect tiny spots on your lungs many years before the spots can be seen on a chest x-ray. Early detection is our best hope for effective treatment and possible cure for lung cancer.
The Legacy Study also examines the impact of providing smoking cessation advice and counseling practices on smoking behavior and smoking related health beliefs in smokers seeking lung cancer screening
Am I a candidate for this study?
To be a candidate for this study:
- You must be at least 50 years old.
- You must have you smoked the equivalent of one pack per day for 10 years.
- If you are a current smoker, would you consider quitting?
- You must be physically fit enough to have lung surgery if necessary.
- You must have a primary care physician.
What do I need to do?
To participate in this lung cancer research study:
- You will need to complete a detailed questionnaire.
- You will undergo a free low-dose CT (CAT, Computed tomography) scan of the chest to see if you have any abnormalities in your chest.
- If no abnormalities exist, you will be scheduled for another free CT scan one year after your first scan.
- If you have abnormalities, other tests or procedures might be recommended to you and your physician as follow-up.
- If you are a current smoker, you may be randomized to receive brief smoking cessation counseling session prior to your first CT Scan.
- You will participate in the study for 12 months, but you can stop participating at any time.
If you are interested in participating in this lung cancer research study, please contact:
Yonas Assefa, research assistant
Holy Cross Hospital, Clinical Research Department
301-754-7695
assefy@holycrosshealth.org
lungcarecenter@holycrosshealth.org
Ana Fighetti, bilingual research assistant (Spanish)
301-754-7998
Principal Investigator for I-ELCAP:
Cheryl Aylesworth, MD, medical oncologist
Principal Investigator for Legacy:
Kashif Firozvi, MD, medical oncologist
Return to top.
|
